Bristol-Myers Squibb Company Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.49B | 12.50B | 12.22B | 12.27B | 11.20B | 12.34B | 11.89B | 12.20B |
| Cost of Goods Sold | 3.42B | 4.10B | 3.44B | 4.20B | 3.86B | 4.92B | 5.28B | 5.40B |
| Gross Profit | 8.07B | 8.40B | 8.79B | 8.07B | 7.34B | 7.42B | 6.62B | 6.80B |
| R&D Expenses | 2.65B | 2.59B | 2.53B | 2.26B | 2.24B | 2.79B | 2.35B | 2.29B |
| Operating Expenses | 4.80B | 6.99B | 5.15B | 3.95B | 3.82B | 4.89B | 4.33B | 4.22B |
| Operating Income | 3.27B | 1.42B | 3.64B | 4.12B | 3.52B | 2.53B | 2.29B | 2.58B |
| Other Income / Gains | -31.0M | 51.0M | -525.0M | -2.34B | -550.0M | -2.36B | -612.0M | -1.30B |
| Net Income | 2.68B | 1.09B | 2.20B | 1.31B | 2.46B | 72.0M | 1.21B | 1.68B |
| EPS (Diluted) | 1.31 | 0.53 | 1.08 | 0.64 | 1.21 | 0.036 | 0.60 | 0.83 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.702 | 0.672 | 0.719 | 0.658 | 0.655 | 0.602 | 0.556 | 0.557 |
| General And Administrative Expenses | 0 | 2.18B | 0 | 0 | 0 | 352.0M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 1.58B | 1.50B | 1.98B | 0 |
| Selling General And Administrative Expenses | 1.62B | 2.18B | 1.79B | 1.69B | 1.58B | 1.85B | 1.98B | 1.92B |
| Other Expenses | 531.0M | 2.22B | 831.0M | 0 | 0 | 253.0M | 0 | 0 |
| Cost And Expenses | 8.22B | 11.08B | 8.58B | 8.15B | 7.68B | 9.81B | 9.60B | 9.62B |
| Interest Income | 0 | 0 | 161.0M | 139.0M | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 51.0M | 480.0M | 485.0M | 494.0M | 496.0M | 505.0M | 521.0M |
| Depreciation And Amortization | 437.0M | 826.0M | 993.0M | 1.03B | 1.01B | 1.88B | 2.59B | 2.60B |
| Ebitda | 3.71B | 2.19B | 4.59B | 3.29B | 4.48B | 2.55B | 4.77B | 4.40B |
| Ebitdaratio | 0.323 | 0.175 | 0.375 | 0.268 | 0.40 | 0.207 | 0.401 | 0.361 |
| Operating Income Ratio | 0.285 | 0.114 | 0.298 | 0.336 | 0.314 | 0.205 | 0.192 | 0.212 |
| Income Before Tax | 3.24B | 1.47B | 3.11B | 1.77B | 2.97B | 175.0M | 1.68B | 1.29B |
| Income Before Tax Ratio | 0.282 | 0.118 | 0.255 | 0.145 | 0.265 | 0.014 | 0.141 | 0.105 |
| Income Tax Expense | 561.0M | 384.0M | 919.0M | 460.0M | 509.0M | 99.0M | 461.0M | -398.0M |
| Net Income Ratio | 0.233 | 0.087 | 0.18 | 0.107 | 0.219 | 0.006 | 0.102 | 0.138 |
| Epsdiluted | 1.31 | 0.53 | 1.08 | 0.64 | 1.20 | 0.035 | 0.60 | 0.83 |
| Weighted Average Shs Out | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B | 2.03B | 2.03B |
| Weighted Average Shs Out Dil | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B |